U.S. Logistics Stock News

NYSE:ATMU
NYSE:ATMUMachinery

Atmus Filtration Technologies (ATMU) Margin Expansion Reinforces Bullish Earnings Narratives

Atmus Filtration Technologies (ATMU) has capped FY 2025 with Q4 revenue of US$446.6 million and basic EPS of US$0.59. Trailing twelve month revenue landed at US$1.76 billion with EPS of US$2.52 and net income of US$207.4 million. The company has seen quarterly revenue move from US$403.7 million and EPS of US$0.53 in Q3 2024 to the current Q4 2025 levels. Trailing twelve month EPS has stepped up from US$2.16 to US$2.52 over the same comparison points, setting up a results season where...
NYSE:RPC
NYSE:RPCCapital Markets

Ridgepost Capital (RPC) Valuation Check After Rebrand And High P/E Versus Peers

Why Ridgepost Capital Is On Investors’ Radar Ridgepost Capital (RPC) recently rebranded from P10, Inc. This shift is putting fresh attention on how this multi asset class private market solutions provider is positioned across private equity, venture capital, impact investing, and private credit. See our latest analysis for Ridgepost Capital. At a latest share price of $8.70, Ridgepost Capital has seen a 2.35% 1 day share price return. Its 30 day share price return of 18.77% and 1 year total...
NYSE:AKR
NYSE:AKRRetail REITs

Acadia Realty Trust (AKR) FFO Stability Reinforces Bullish Urban Retail Narratives

Acadia Realty Trust (AKR) has wrapped up FY 2025 with fourth quarter revenue of US$106.7 million and basic EPS of US$0.04, alongside funds from operations of US$41.6 million, which is a key earnings gauge for REIT investors. The company has seen quarterly revenue move from US$92.8 million in Q4 2024 to US$106.7 million in Q4 2025, while basic EPS shifted from US$0.07 to US$0.04 over the same period. Investors may now weigh the solid top line momentum against margins that are likely to be...
NasdaqCM:NEO
NasdaqCM:NEOHealthcare

NeoGenomics PanTracer Pro Launch Sets New Test Against Weak Share Performance

NeoGenomics, NasdaqCM:NEO, has launched PanTracer Pro, a new diagnostic solution for clinicians treating advanced stage solid tumors. The offering combines broad genomic profiling and customized diagnostic testing into a single order with a focus on faster turnaround times. PanTracer Pro is designed to address fragmented testing workflows, treatment delays, and incomplete biomarker assessment in cancer care. NeoGenomics, trading at $11.38, has seen mixed share price performance, with a 30...
NYSE:NSC
NYSE:NSCTransportation

Norfolk Southern Union Pacific Merger Reshapes Rail Network And Risk Profile

Norfolk Southern (NYSE:NSC) has entered into a merger agreement with Union Pacific to form what is described as America's first transcontinental railroad. The transaction comes while Norfolk Southern continues to face legal proceedings related to the 2023 East Palestine incident. These developments are expected to affect the company's operations, regulatory profile, and position within the North American rail industry. For investors watching Norfolk Southern at a share price of $314.94,...
NYSE:NVST
NYSE:NVSTMedical Equipment

Should Envista’s Profit Turn, Product Launches and Buybacks Require Action From Envista Holdings (NVST) Investors?

Envista Holdings reported its fourth-quarter and full-year 2025 results in early February 2026, with quarterly sales of US$750.6 million and net income of US$32.9 million, and full-year sales of US$2.72 billion alongside a return to profitability with net income of US$47 million. Alongside these results, Envista highlighted nearly US$100 million in revenue from new product launches, guided to 2%–4% core sales growth for 2026, and completed a buyback of 9.17 million shares, or 5.4% of its...